Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(24):1892; doi:10.1093/jnci/94.24.1892
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hemminki, K.
Right arrow Articles by Granström, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hemminki, K.
Right arrow Articles by Granström, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 24, 1892, December 18, 2002
© 2002 Oxford University Press


CORRESPONDENCE

Re: Risk of Subsequent Cancer Following Breast Cancer in Men

Kari Hemminki, Charlotta Granström

Affiliations of authors: K. Hemminki, Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden, and Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; C. Granström, Department of Biosciences at Novum, Karolinska Institute, Huddinge.

Correspondence to: Kari Hemminki, M.D., Ph.D., CNT Novum, 141 57, Sweden (e-mail: kari. hemminki@cnt.ki.se).

The first 10% of the full text of this article appears below.

Auvinen et al. (1) published results on male breast cancer based on the Surveillance, Epidemiology, and End Results (SEER)1 data source. They showed a standardized incidence ratio (SIR) for contralateral breast cancer of 29.64 in 12 individuals. Melanoma was also in excess after breast cancer (SIR = 2.41). However, when breast cancer was analyzed as a second primary cancer after any other type of cancer, no statistically significant increases were observed.

In . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?